Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

Frederick J. Raal(University of the Witwatersrand), Raúl D. Santos(Universidade de São Paulo), Dirk Blom(University of Cape Town), A. David Marais(University of Cape Town), Min‐Ji Charng(Taipei Veterans General Hospital), William C. Cromwell, Robin Lachmann(University College London), Daniel Gaudet(Université de Montréal), Ju Le Tan(National Heart Centre Singapore), Scott Chasan-Taber, Diane L. Tribble(Ionis Pharmaceuticals (United States)), JoAnn Flaim(Ionis Pharmaceuticals (United States)), Stanley T. Crooke(Ionis Pharmaceuticals (United States))
The Lancet
March 1, 2010
Cited by 903

Abstract


Related Papers

No related papers found

Powered by citation graph analysis